Success Metrics

Clinical Success Rate
71.4%

Based on 5 completed trials

Completion Rate
71%(5/7)
Active Trials
1(7%)
Results Posted
80%(4 trials)
Terminated
2(14%)

Phase Distribution

Ph phase_2
5
36%
Ph not_applicable
3
21%
Ph early_phase_1
2
14%
Ph phase_1
1
7%
Ph phase_4
2
14%

Phase Distribution

3

Early Stage

5

Mid Stage

2

Late Stage

Phase Distribution13 total trials
Early Phase 1First-in-human
2(15.4%)
Phase 1Safety & dosage
1(7.7%)
Phase 2Efficacy & side effects
5(38.5%)
Phase 4Post-market surveillance
2(15.4%)
N/ANon-phased studies
3(23.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

62.5%

5 of 8 finished

Non-Completion Rate

37.5%

3 ended early

Currently Active

1

trials recruiting

Total Trials

14

all time

Status Distribution
Active(5)
Completed(5)
Terminated(3)
Other(1)

Detailed Status

Completed5
Not yet recruiting3
Terminated2
unknown1
Enrolling by invitation1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
14
Active
1
Success Rate
71.4%
Most Advanced
Phase 4

Trials by Phase

Early Phase 12 (15.4%)
Phase 11 (7.7%)
Phase 25 (38.5%)
Phase 42 (15.4%)
N/A3 (23.1%)

Trials by Status

terminated214%
unknown17%
completed536%
enrolling_by_invitation17%
not_yet_recruiting321%
recruiting17%
withdrawn17%

Recent Activity

1 active trials
Showing 5 of 14
not_yet_recruitingnot_applicable

Dexmedetomidine Versus Ketamine as Adjuvants in Bariatric Surgery

NCT06738043
withdrawn

Electroencephalographic (EEG) Profils for Patients on Intravenous Ketamine.

NCT05949554
completedphase_2

Ketamine for the Treatment of Depression in Parkinson's Disease

NCT04944017
completednot_applicable

Perioperative Opioid-induced Hyperalgesia and Its Prevention With Ketamine and Methadone

NCT01594047
terminatedphase_2

Reducing Adolescent Suicide Risk: Safety, Efficacy, and Connectome Phenotypes of Intravenous Ketamine

NCT04613453
View all 14 trials

Clinical Trials (14)

Showing 14 of 14 trials
NCT06738043Not Applicable

Dexmedetomidine Versus Ketamine as Adjuvants in Bariatric Surgery

Not Yet Recruiting
NCT05949554

Electroencephalographic (EEG) Profils for Patients on Intravenous Ketamine.

Withdrawn
NCT04944017Phase 2

Ketamine for the Treatment of Depression in Parkinson's Disease

Completed
NCT01594047Not Applicable

Perioperative Opioid-induced Hyperalgesia and Its Prevention With Ketamine and Methadone

Completed
NCT04613453Phase 2

Reducing Adolescent Suicide Risk: Safety, Efficacy, and Connectome Phenotypes of Intravenous Ketamine

Terminated
NCT06736769Phase 2

Ketamine Effects on Learning In Eating Disorders

Enrolling By Invitation
NCT07009158Phase 1

Ketamine Assisted Psychotherapy for Treating Comorbid Chronic Pain and PTSD

Not Yet Recruiting
NCT06935552Early Phase 1

Ketamine and Lidocaine Infusion in Refractory Chronic Migraine

Not Yet Recruiting
NCT06774274Phase 4

Analgesic Efficacy of Intravenous Ketamine as a Continuous Infusion vs PCA in the Management of Acute Postoperative Pain in Major Orthopedic Surgery.

Recruiting
NCT01480765Phase 4

Preventing Pain After Heart Surgery

Completed
NCT03889756Phase 2

Ketamine for Severe Adolescent Depression: Intermediate-term Safety and Efficacy

Terminated
NCT03896256Early Phase 1

Ketamine for Refractory Chronic Migraine: a Pilot Study

Completed
NCT01100255Phase 2

Pilot Study of Ketamine in Adults With Obsessive-Compulsive Disorder (OCD)

Completed
NCT01997801Not Applicable

Ketamine in Robot-assisted Thyroidectomy

Unknown

All 14 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
14